SI-BONE, Inc. (SIBN): Price and Financial Metrics

SI-BONE, Inc. (SIBN): $18.09

1.04 (+6.10%)

POWR Rating

Component Grades














  • SIBN scores best on the Growth dimension, with a Growth rank ahead of 59.67% of US stocks.
  • The strongest trend for SIBN is in Stability, which has been heading down over the past 179 days.
  • SIBN's current lowest rank is in the Sentiment metric (where it is better than 21.8% of US stocks).

SIBN Stock Summary

  • SIBN's went public 4.3 years ago, making it older than only 20.51% of listed US stocks we're tracking.
  • The ratio of debt to operating expenses for SI-BONE INC is higher than it is for about just 24.54% of US stocks.
  • SIBN's price/sales ratio is 5.89; that's higher than the P/S ratio of 79.92% of US stocks.
  • If you're looking for stocks that are quantitatively similar to SI-BONE INC, a group of peers worth examining would be SVFD, APYX, XXII, BLDE, and IRTC.
  • Visit SIBN's SEC page to see the company's official filings. To visit the company's web site, go to

SIBN Valuation Summary

  • In comparison to the median Healthcare stock, SIBN's price/sales ratio is 13.73% higher, now standing at 5.8.
  • Over the past 52 months, SIBN's price/earnings ratio has gone up 15.5.

Below are key valuation metrics over time for SIBN.

Stock Date P/S P/B P/E EV/EBIT
SIBN 2023-01-30 5.8 5.6 -8.9 -9.5
SIBN 2023-01-27 6.0 5.8 -9.2 -9.8
SIBN 2023-01-26 6.0 5.8 -9.2 -9.8
SIBN 2023-01-25 5.9 5.7 -9.1 -9.7
SIBN 2023-01-24 6.1 5.9 -9.3 -9.9
SIBN 2023-01-23 6.1 5.9 -9.4 -9.9

SIBN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SIBN has a Quality Grade of C, ranking ahead of 32.78% of graded US stocks.
  • SIBN's asset turnover comes in at 0.425 -- ranking 111th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows SIBN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.425 0.889 -0.227
2021-03-31 0.409 0.881 -0.230
2020-12-31 0.417 0.879 -0.268
2020-09-30 0.475 0.878 -0.305
2020-06-30 0.473 0.884 -0.313
2020-03-31 0.519 0.896 -0.281

SIBN Price Target

For more insight on analysts targets of SIBN, see our SIBN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $40.86 Average Broker Recommendation 1.36 (Strong Buy)

SIBN Stock Price Chart Interactive Chart >

Price chart for SIBN

SIBN Price/Volume Stats

Current price $18.09 52-week high $23.71
Prev. close $17.05 52-week low $11.14
Day low $16.69 Volume 227,599
Day high $18.11 Avg. volume 222,455
50-day MA $13.90 Dividend yield N/A
200-day MA $15.45 Market Cap 624.03M

SI-BONE, Inc. (SIBN) Company Bio

SI-BONE, Inc. engages in the development of invasive surgical implant system. Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded on April 2008 by Mark A. Reiley and Jeffrey W. Dunn in and is headquartered in San Jose, CA.

SIBN Latest News Stream

Event/Time News Detail
Loading, please wait...

SIBN Latest Social Stream

Loading social stream, please wait...

View Full SIBN Social Stream

Latest SIBN News From Around the Web

Below are the latest news stories about SI-BONE INC that investors may wish to consider to help them evaluate SIBN as an investment opportunity.

SI-BONE Inc. (NASDAQ: SIBN) Stock Jumped 44.50% Over A Month – Is There Any Hope Of A Gain?

During the last session, SI-BONE Inc. (NASDAQ:SIBN)’s traded shares were 0.33 million, with the beta value of the company hitting 0.93. At the end of the trading day, the stock’s price was $17.21, reflecting an intraday gain of 6.23% or $1.01. The 52-week high for the SIBN share is $23.71, that puts it down -37.77 … SI-BONE Inc. (NASDAQ: SIBN) Stock Jumped 44.50% Over A Month – Is There Any Hope Of A Gain? Read More »

Marketing Sentinel | January 21, 2023

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022

Fourth Quarter revenue of $31.7 - $31.9 million representing growth of approximately 26% Fiscal Year 2022 revenue of $106.1 - $106.3 million representing growth of approximately 18%

GlobeNewswire | January 9, 2023

SI-BONE guides Q4 and FY22 revenue above estimates

SI-Bone (SIBN) expects Q4 worldwide revenue to be in the range of $31.7M-$31.9M, representing growth of ~26% Y/Y, vs consensus of $30.05M.Q4 U.S. revenue expected to be in the range…

Seeking Alpha | January 9, 2023

SI-BONE to Host a Virtual Fireside Chat at the 25th Annual Needham Growth Conference

SANTA CLARA, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 25th Annual Needham Growth Conference. Management will be hosting a virtual fireside chat on Thursday, January 12th, 2023, at 11:45 a.m. Eastern Time / 8:45 a.m. Pacific Time. A live webcast of each event, as well as an archived recording will

Yahoo | January 3, 2023

SI-BONE Stock: Multiple Inflection Points On The Horizon In FY 2023 (NASDAQ:SIBN)

SI-BONE presents as an operator in the surgical intervention of sacroiliac disorders. There are inflection points on the horizon. See why we believe SIBN is a buy.

Seeking Alpha | December 30, 2022

Read More 'SIBN' Stories Here

SIBN Price Returns

1-mo 35.81%
3-mo 9.57%
6-mo 8.39%
1-year -5.49%
3-year -13.98%
5-year N/A
YTD 33.01%
2022 -38.77%
2021 -25.72%
2020 39.07%
2019 2.92%
2018 N/A

Continue Researching SIBN

Here are a few links from around the web to help you further your research on SI-BONE Inc's stock as an investment opportunity:

SI-BONE Inc (SIBN) Stock Price | Nasdaq
SI-BONE Inc (SIBN) Stock Quote, History and News - Yahoo Finance
SI-BONE Inc (SIBN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6773 seconds.